The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.07BCNY
310.90M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue (TTM)
557.57MCNY
83.58M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
-9.06%
vs Conglomerates peers
Updated Oct 22, 2026
52-Week Change
-27.87%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
2.07BCNY
310.90M · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
1.83BCNY
274.43M · vs all stocks (USD)
Updated Oct 22, 2026
Price to Sales (TTM)
3.87x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 3.72×.Updated Oct 22, 2026
Price to Book (MRQ)
1.24x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to Revenue
3.28x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to EBITDA
39.77x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 44.61×.Updated Oct 22, 2026
Gross Margin
20.39%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 28.21%.Updated Oct 22, 2026
Profit Margin
-9.06%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Margin
15.41%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Assets (TTM)
0.83%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Equity (TTM)
-2.88%
vs Conglomerates peers
Updated Oct 22, 2026
Revenue (TTM)
557.57MCNY
83.58M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
0.8730CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
25.30%
vs Conglomerates peers
Updated Oct 22, 2026
Gross Profit (TTM)
157.31MCNY
23.58M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
41.04MCNY
6.15M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
-50.49MCNY
-7.57M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
67.60%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
663.63MCNY
99.48M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
690.52MCNY
103.51M · vs all stocks (USD)
Updated Oct 22, 2026
5-Year Average Dividend Yield
0.67%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Oct 22, 2026
Revenue
449.24MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
355.49MCNYFY2025 · Dec 31, 2025
Gross Profit
93.75MCNYFY2025 · Dec 31, 2025
Operating Income
28.73MCNY
4.31M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-59.60MCNYFY2025 · Dec 31, 2025
Income Tax Expense
13.38MCNYFY2025 · Dec 31, 2025
Net Income
-72.98MCNYFY2025 · Dec 31, 2025
EBIT
-14.80MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
41.04MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
11.64MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
41.04MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.13MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
44.80MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1130CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1130CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
645.87MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
645.87MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-72.98MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
336.93MCNYFY2025 · Dec 31, 2025
Free Cash Flow
336.02MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
249.55MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-72.98MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
44.80MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
33.74MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
331.37MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-911.90KCNYFY2025 · Dec 31, 2025
Net Acquisitions
19.58MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-115.64MCNYFY2025 · Dec 31, 2025
Sale of Investments
479.53KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-96.49MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
110.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-946.74MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-32.39MCNYFY2025 · Dec 31, 2025
Other Financing Charges
2.44MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-866.69MCNYFY2025 · Dec 31, 2025
Shares Outstanding
646.12MSharesUpdated Oct 22, 2026
Float Shares
456.05MSharesUpdated Oct 22, 2026
% Held by Insiders
32.44%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
0.67%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
684.31MCNY
102.58M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
1.06CNYUpdated Oct 22, 2026
Total Debt (MRQ)
363.65MCNY
54.51M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.2104x
vs Conglomerates peers
Updated Oct 22, 2026
Current Ratio (MRQ)
3.57x
vs Conglomerates peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
2.68CNYUpdated Oct 22, 2026
Total Assets
2.51BCNY
375.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.92BCNYFY2025 · Dec 31, 2025
Total Liabilities
803.95MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
589.47MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
59.68MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
744.27MCNYFY2025 · Dec 31, 2025
Cash
249.55MCNYFY2025 · Dec 31, 2025
Cash Equivalents
50.00MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
299.55MCNYFY2025 · Dec 31, 2025
Accounts Receivable
13.58MCNYFY2025 · Dec 31, 2025
Inventory
1.48BCNYFY2025 · Dec 31, 2025
Accounts Payable
26.44MCNYFY2025 · Dec 31, 2025
Short-term Debt
508.61MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.65MCNYFY2025 · Dec 31, 2025
Long-term Debt
36.17MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
646.12MCNYFY2025 · Dec 31, 2025
Retained Earnings
523.26MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.70BCNY
255.29M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
2.39CNYUpdated Oct 22, 2026
52-Week High
5.68CNYUpdated Oct 22, 2026
52-Week Change
-27.87%
vs all stocks
Updated Oct 22, 2026
50-Day MA
3.11CNYUpdated Oct 22, 2026
200-Day MA
3.39CNYUpdated Oct 22, 2026
Avg 10-Day Volume
5.91MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
7.85MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
-0.1100CNYUpdated Oct 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.56: grey zoneSignificant
Altman Z-Score: 2.56
High earnings qualityNotable
Earnings Quality Score: 21.78
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Levered free cash flow is $103.51M, above the global median of $18.58MNotable